Ne Rx Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NE RX PHARMA, and what generic and branded alternatives to NE RX PHARMA drugs are available?
NE RX PHARMA has four approved drugs.
Summary for Ne Rx Pharma
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Ne Rx Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ne Rx Pharma | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 216786-001 | Feb 1, 2024 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Ne Rx Pharma | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 216786-002 | Feb 1, 2024 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Ne Rx Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197-001 | May 9, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Ne Rx Pharma | METOLAZONE | metolazone | TABLET;ORAL | 216216-002 | Oct 25, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
